These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1912 related items for PubMed ID: 29338754

  • 1. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK, Park J, Han D, Yang J, Kim A, Woo J, Kim Y, Mook-Jung I.
    Mol Neurodegener; 2018 Jan 16; 13(1):2. PubMed ID: 29338754
    [Abstract] [Full Text] [Related]

  • 2. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model.
    Kim MS, Kim Y, Choi H, Kim W, Park S, Lee D, Kim DK, Kim HJ, Choi H, Hyun DW, Lee JY, Choi EY, Lee DS, Bae JW, Mook-Jung I.
    Gut; 2020 Feb 16; 69(2):283-294. PubMed ID: 31471351
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.
    Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM.
    Neurobiol Aging; 2003 Dec 16; 24(8):1063-70. PubMed ID: 14643377
    [Abstract] [Full Text] [Related]

  • 5. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A, Xu X, Bi X, Baudry M.
    J Alzheimers Dis; 2012 Dec 16; 30(1):183-208. PubMed ID: 22406441
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
    Kurt MA, Davies DC, Kidd M, Duff K, Howlett DR.
    Neurobiol Dis; 2003 Oct 16; 14(1):89-97. PubMed ID: 13678670
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease.
    Stancu IC, Ris L, Vasconcelos B, Marinangeli C, Goeminne L, Laporte V, Haylani LE, Couturier J, Schakman O, Gailly P, Pierrot N, Kienlen-Campard P, Octave JN, Dewachter I.
    FASEB J; 2014 Jun 16; 28(6):2620-31. PubMed ID: 24604080
    [Abstract] [Full Text] [Related]

  • 10. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
    Saul A, Sprenger F, Bayer TA, Wirths O.
    Neurobiol Aging; 2013 Nov 16; 34(11):2564-73. PubMed ID: 23747045
    [Abstract] [Full Text] [Related]

  • 11. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF, Blanchard J, Dai CL, Tung YC, LaFerla FM, Iqbal IG, Iqbal K.
    Neurobiol Dis; 2014 Nov 16; 71():110-30. PubMed ID: 25046994
    [Abstract] [Full Text] [Related]

  • 12. Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease.
    Paulson JB, Ramsden M, Forster C, Sherman MA, McGowan E, Ashe KH.
    Am J Pathol; 2008 Sep 16; 173(3):762-72. PubMed ID: 18669616
    [Abstract] [Full Text] [Related]

  • 13. Alterations of brain and cerebellar proteomes linked to Aβ and tau pathology in a female triple-transgenic murine model of Alzheimer's disease.
    Ciavardelli D, Silvestri E, Del Viscovo A, Bomba M, De Gregorio D, Moreno M, Di Ilio C, Goglia F, Canzoniero LM, Sensi SL.
    Cell Death Dis; 2010 Oct 28; 1(10):e90. PubMed ID: 21368863
    [Abstract] [Full Text] [Related]

  • 14. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K, Prelli F, Mehta P, MacMurray C, Goñi F, Wisniewski T.
    Alzheimers Res Ther; 2018 Jun 18; 10(1):54. PubMed ID: 29914551
    [Abstract] [Full Text] [Related]

  • 15. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ, Rudinskiy N, Herrmann AG, Croft S, Kim JM, Petrova V, Ramos-Rodriguez JJ, Pitstick R, Wegmann S, Garcia-Alloza M, Carlson GA, Hyman BT, Spires-Jones TL.
    Eur J Neurosci; 2016 Dec 18; 44(12):3056-3066. PubMed ID: 27748574
    [Abstract] [Full Text] [Related]

  • 16. Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice.
    Kapadia M, Mian MF, Michalski B, Azam AB, Ma D, Salwierz P, Christopher A, Rosa E, Zovkic IB, Forsythe P, Fahnestock M, Sakic B.
    J Alzheimers Dis; 2018 Dec 18; 63(3):1191-1205. PubMed ID: 29710702
    [Abstract] [Full Text] [Related]

  • 17. Neurophysiological effects of human-derived pathological tau conformers in the APPKM670/671NL.PS1/L166P amyloid mouse model of Alzheimer's disease.
    Tok S, Maurin H, Delay C, Crauwels D, Manyakov NV, Van Der Elst W, Moechars D, Drinkenburg WHIM.
    Sci Rep; 2022 May 11; 12(1):7784. PubMed ID: 35546164
    [Abstract] [Full Text] [Related]

  • 18. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T, Iwashita H, Uno Y, Kunitomo J, Saitoh M, Kimura E, Fujita H, Uchiyama N, Kori M, Takizawa M.
    J Neurochem; 2011 Dec 11; 119(6):1330-40. PubMed ID: 21992552
    [Abstract] [Full Text] [Related]

  • 19. Biochemical and morphological characterization of the AβPP/PS/tau triple transgenic mouse model and its relevance to sporadic Alzheimer's disease.
    Hunter JM, Bowers WJ, Maarouf CL, Mastrangelo MA, Daugs ID, Kokjohn TA, Kalback WM, Luehrs DC, Valla J, Beach TG, Roher AE.
    J Alzheimers Dis; 2011 Dec 11; 27(2):361-76. PubMed ID: 21860086
    [Abstract] [Full Text] [Related]

  • 20. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
    Götz J, Schild A, Hoerndli F, Pennanen L.
    Int J Dev Neurosci; 2004 Nov 11; 22(7):453-65. PubMed ID: 15465275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 96.